Molecular and Electrophysiological Role of Diabetes-Associated Circulating Inflammatory Factors in Cardiac Arrhythmia Remodeling in a Metabolic-Induced Model of Type 2 Diabetic Rat.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
25 Jun 2021
Historique:
received: 18 05 2021
revised: 16 06 2021
accepted: 22 06 2021
entrez: 2 7 2021
pubmed: 3 7 2021
medline: 27 7 2021
Statut: epublish

Résumé

Diabetic patients have prolonged cardiac repolarization and higher risk of arrhythmia. Besides, diabetes activates the innate immune system, resulting in higher levels of plasmatic cytokines, which are described to prolong ventricular repolarization. We characterize a metabolic model of type 2 diabetes (T2D) with prolonged cardiac repolarization. Sprague-Dawley rats were fed on a high-fat diet (45% Kcal from fat) for 6 weeks, and a low dose of streptozotozin intraperitoneally injected at week 2. Body weight and fasting blood glucose were measured and electrocardiograms of conscious animals were recorded weekly. Plasmatic lipid profile, insulin, cytokines, and arrhythmia susceptibility were determined at the end of the experimental period. Outward K T2D animals showed insulin resistance, hyperglycemia, and elevated levels of plasma cholesterol, triglycerides, TNFα, and IL-1b. They also developed bradycardia and prolonged QTc-interval duration that resulted in increased susceptibility to severe ventricular tachycardia under cardiac challenge. Action potential duration (APD) was prolonged in control cardiomyocytes incubated 24 h with plasma isolated from diabetic rats. However, adding TNFα and IL-1b receptor blockers to the serum of diabetic animals prevented the increased APD. The elevation of the circulating levels of TNFα and IL-1b are responsible for impaired ventricular repolarization and higher susceptibility to cardiac arrhythmia in our metabolic model of T2D.

Sections du résumé

BACKGROUND BACKGROUND
Diabetic patients have prolonged cardiac repolarization and higher risk of arrhythmia. Besides, diabetes activates the innate immune system, resulting in higher levels of plasmatic cytokines, which are described to prolong ventricular repolarization.
METHODS METHODS
We characterize a metabolic model of type 2 diabetes (T2D) with prolonged cardiac repolarization. Sprague-Dawley rats were fed on a high-fat diet (45% Kcal from fat) for 6 weeks, and a low dose of streptozotozin intraperitoneally injected at week 2. Body weight and fasting blood glucose were measured and electrocardiograms of conscious animals were recorded weekly. Plasmatic lipid profile, insulin, cytokines, and arrhythmia susceptibility were determined at the end of the experimental period. Outward K
RESULTS RESULTS
T2D animals showed insulin resistance, hyperglycemia, and elevated levels of plasma cholesterol, triglycerides, TNFα, and IL-1b. They also developed bradycardia and prolonged QTc-interval duration that resulted in increased susceptibility to severe ventricular tachycardia under cardiac challenge. Action potential duration (APD) was prolonged in control cardiomyocytes incubated 24 h with plasma isolated from diabetic rats. However, adding TNFα and IL-1b receptor blockers to the serum of diabetic animals prevented the increased APD.
CONCLUSIONS CONCLUSIONS
The elevation of the circulating levels of TNFα and IL-1b are responsible for impaired ventricular repolarization and higher susceptibility to cardiac arrhythmia in our metabolic model of T2D.

Identifiants

pubmed: 34202017
pii: ijms22136827
doi: 10.3390/ijms22136827
pmc: PMC8268936
pii:
doi:

Substances chimiques

Biomarkers 0
Cytokines 0
Inflammation Mediators 0
Insulin 0
Potassium Channels 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Eusko Jaurlaritza
ID : PIBA2018-58
Organisme : Eusko Jaurlaritza
ID : GIC18/150
Organisme : European Cooperation in Science and Technology
ID : CA16225

Références

Diabetes. 2011 Nov;60(11):2963-74
pubmed: 21933987
J Cardiovasc Pharmacol. 1990 Sep;16(3):401-10
pubmed: 1700210
Diabet Med. 2011 Oct;28(10):1206-12
pubmed: 21388447
Heart Fail Rev. 2020 May;25(3):537-548
pubmed: 31705352
Br Heart J. 1988 Mar;59(3):379-83
pubmed: 3355728
J Mol Cell Cardiol. 2014 Nov;76:116-25
pubmed: 25169970
J Physiol. 2017 Apr 1;595(7):2229-2252
pubmed: 27808412
J Mol Cell Cardiol. 1992 Aug;24(8):841-53
pubmed: 1433314
J Mol Cell Cardiol. 2010 Jan;48(1):12-25
pubmed: 19619557
J Electrocardiol. 2020 Mar - Apr;59:116-121
pubmed: 32062380
Am J Physiol Endocrinol Metab. 2010 Jan;298(1):E38-48
pubmed: 19843874
World J Diabetes. 2019 May 15;10(5):280-290
pubmed: 31139315
BMJ. 1998 Mar 7;316(7133):745-6
pubmed: 9529410
J Clin Endocrinol Metab. 1987 Apr;64(4):751-4
pubmed: 3818902
Life Sci. 2021 Jul 1;276:119374
pubmed: 33745896
Front Physiol. 2020 Jan 29;10:1607
pubmed: 32063863
Diabetologia. 2000 Jan;43(1):101-9
pubmed: 10672450
Cardiovasc Res. 2007 Feb 1;73(3):512-20
pubmed: 17182020
Curr Diab Rep. 2004 Jun;4(3):187-93
pubmed: 15132883
Biology (Basel). 2019 Dec 25;9(1):
pubmed: 31881657
Rheumatology (Oxford). 2020 Nov 1;59(11):e88-e90
pubmed: 32533180
Lancet. 2013 Jun 1;381(9881):1905-15
pubmed: 23562090
Curr Heart Fail Rep. 2017 Aug;14(4):251-265
pubmed: 28667492
Diabetes Care. 2010 Apr;33(4):861-8
pubmed: 20067962
Heart Rhythm. 2017 Aug;14(8):1131-1137
pubmed: 28552749
Cardiovasc Diabetol. 2021 Jun 1;20(1):116
pubmed: 34074290
Aging (Albany NY). 2020 May 3;12(9):8423-8433
pubmed: 32364529
J Diabetes Res. 2016;2016:2848759
pubmed: 27642609
J Clin Endocrinol Metab. 2008 Feb;93(2):578-83
pubmed: 18029454
Cardiovasc Diabetol. 2019 Jun 4;18(1):72
pubmed: 31164120
Pharmacol Ther. 2013 Aug;139(2):213-48
pubmed: 23588158
Acta Physiol (Oxf). 2013 Mar;207(3):447-59
pubmed: 23181465
Nat Commun. 2016 Nov 24;7:13344
pubmed: 27882934
Am J Physiol Heart Circ Physiol. 2007 Jul;293(1):H238-45
pubmed: 17337591
Circulation. 1998 Nov 3;98(18):1928-36
pubmed: 9799215
Dis Model Mech. 2017 Feb 1;10(2):151-162
pubmed: 28093504
Metabolism. 2000 Nov;49(11):1390-4
pubmed: 11092499
Diabetes. 2013 Jan;62(1):194-204
pubmed: 23086037
Nature. 2006 Mar 23;440(7083):463-9
pubmed: 16554806
Acta Physiol (Oxf). 2008 Mar;192(3):359-68
pubmed: 17970826
J Ethnopharmacol. 2020 Oct 5;260:113099
pubmed: 32535241
Nature. 2013 Oct 17;502(7471):372-6
pubmed: 24077098
Pediatr Diabetes. 2018 Jun;19(4):788-793
pubmed: 29504185

Auteurs

Julian Zayas-Arrabal (J)

Departament of Physiology, Facultad de Farmacia, Universidad del País Vasco UPV/EHU, 01006 Vitoria-Gasteiz, Spain.

Amaia Alquiza (A)

Departament of Physiology, Facultad de Farmacia, Universidad del País Vasco UPV/EHU, 01006 Vitoria-Gasteiz, Spain.

Erkan Tuncay (E)

Department of Biophysics, Faculty of Medicine, Ankara University, 06100 Ankara, Turkey.

Belma Turan (B)

Department of Biophysics, Faculty of Medicine, Lokman Hekim University, 06510 Ankara, Turkey.

Monica Gallego (M)

Departament of Physiology, Facultad de Farmacia, Universidad del País Vasco UPV/EHU, 01006 Vitoria-Gasteiz, Spain.

Oscar Casis (O)

Departament of Physiology, Facultad de Farmacia, Universidad del País Vasco UPV/EHU, 01006 Vitoria-Gasteiz, Spain.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
C-Reactive Protein Humans Biomarkers Inflammation
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice

Classifications MeSH